Other
Net unrealized gains (losses) on securities still held
Year-over-year, this metric declined by 454.6%, from $1.03M to -$3.65M. Over 3 years (FY 2021 to FY 2025), Net unrealized gains (losses) on securities still held shows an upward trend with a -2.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase reflects positive market performance of the company's investment portfolio, potentially signaling latent liquidity.
Detailed definition
The change in the fair value of investment securities held by the company that are classified as available-for-sale or s...
Peer comparison
Standard for companies with significant cash reserves invested in marketable securities.
Metric ID:
other_other_comprehensive_income_unrealized_holding_gain_503fecHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$247.00K | -$64.00K | -$1.67M | -$7.22M | -$1.73M | -$2.05M | $4.13M | -$2.03M | $1.88M | $7.04M | -$3.57M | -$727.00K | $9.08M | -$4.79M | $1.03M | -$343.00K | $1.13M | $0.00 | -$3.65M |
| QoQ Change | — | +74.1% | <-999% | -333.2% | +76.0% | -18.4% | +300.9% | -149.1% | +192.7% | +274.9% | -150.7% | +79.6% | >999% | -152.7% | +121.5% | -133.3% | +429.7% | -100.0% | — |
| YoY Change | — | — | — | — | -602.0% | <-999% | +157.2% | -16.8% | +191.5% | — | -186.5% | +64.1% | +383.4% | -168.0% | +128.9% | +52.8% | -87.5% | +100.0% | -454.6% |
Range-$7.22M – $9.08M
CAGR+82.0%
Avg YoY Growth-253.2%
Median YoY Growth+18.0%
Current Streak2 quarters decline
Net unrealized gains (losses) on securities still held at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's net unrealized gains (losses) on securities still held?
- Alnylam Pharmaceuticals (ALNY) reported net unrealized gains (losses) on securities still held of -$3.65M in Q1 2026.
- How has Alnylam Pharmaceuticals's net unrealized gains (losses) on securities still held changed year-over-year?
- Alnylam Pharmaceuticals's net unrealized gains (losses) on securities still held decreased by 454.6% year-over-year, from $1.03M to -$3.65M.
- What is the long-term trend for Alnylam Pharmaceuticals's net unrealized gains (losses) on securities still held?
- Over 3 years (2021 to 2025), Alnylam Pharmaceuticals's net unrealized gains (losses) on securities still held has grown at a -2.8% compound annual growth rate (CAGR), from -$1.98M to $1.82M.
- What does net unrealized gains (losses) on securities still held mean?
- The change in value of investment holdings that have not yet been sold.